Stay updated with breaking news from Momm Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
The testing being developed at the University of Illinois at Chicago and Yale could make diagnosis of the condition more accessible in LMICs.
Momm Diagnostics is currently benchmarking its offering against other tests for preeclampsia, while courting investors to support a new phase of development.